RICHARD STOYKOVICH: Open Payments
NPI 1447623277 · LAFAYETTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 16 payments from 8 companies in 2025. Trend: 2023 $723 · 2024 $459 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $250 |
| AstraZeneca Pharmaceuticals LP | 1 | $138 |
| Novo Nordisk Inc | 2 | $137 |
| Amgen Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $114 |
| Vanda Pharmaceuticals Inc. | 1 | $114 |
| PFIZER INC. | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: JOURNAVX, TEZSPIRE, REPATHA, Ozempic, VOQUEZNA, FANAPT, NURTEC ODT, XTAMPZA.
Industry payments across CA — which companies pay providers there.
